Company / Cash per Share
ARS Pharmaceuticals, Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.42
FY2025
5-year range
$0.42 / $6.93
FY2021-FY2025
Trend
-20.0%
vs FY2024
Sector context
#178 of 205
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s cash per share of $0.42 is lower than 87% of companies in the Health Care sector (FY2025). Cash per Share has declined for 3 consecutive years, from $6.93 in FY2022 to $0.42 in FY2025.
Based on SEC 10-K filings.
0.42 in FY2025 with a 5-year CAGR of -68.4%.
Declined from $0.76 to $0.42 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -60.7%
- 5-Year CAGR
- -68.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 205This company $0.42 Sector average $72.93
▼
-99.4% below sector average
Key checks
Key Insights
- ARS Pharmaceuticals, Inc.'s cash per share has declined for 3 consecutive years.
- In FY2025, cash per share decreased 20.0% year-over-year.
- Ranks #178 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.42 | -20.0% |
| FY2024 | $0.53 | -30.2% |
| FY2023 | $0.76 | -89.1% |
| FY2022 | $6.93 | +233.2% |
| FY2021 | $2.08 | -98.4% |
| FY2020 | $132.95 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026